SCHEMBL8620959

SCHEMBL8620959

CCOC(=O)/C=C/CP(=O)(O)OCC

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.46
HCAR2 Q8TDS4 1/20 0.46
ALDH1A1 P00352 1/20 0.41
PPARD Q03181 1/20 0.41
TTR P02766 1/20 0.37
DPP4 P27487 1/20 0.37
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA7 P43166 1/20 0.37
CA9 Q16790 1/20 0.37
CA14 Q9ULX7 1/20 0.37
NPSR1 Q6W5P4 1/20 0.36
CYP3A4 P08684 1/20 0.36
LMNA P02545 2/20 0.35
RAB9A P51151 1/20 0.34
ATM Q13315 1/20 0.33
FNTA P49354 1/20 0.33
FNTB P49356 1/20 0.33
PGGT1B P53609 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1399032 0.84 MAPT (0.47) MAPTHCAR2ALDH1A1PPARDTTR
SCHEMBL687973 0.84 MAPT (0.47) MAPTHCAR2ALDH1A1PPARDTTR
SCHEMBL8115684 0.83 MAPT (0.50) MAPTHCAR2ALDH1A1TTRDPP4
SCHEMBL8123279 0.83 MAPT (0.50) MAPTHCAR2ALDH1A1TTRDPP4
SCHEMBL15163745 0.82 MAPT (0.46) MAPTHCAR2ALDH1A1TTRDPP4
SCHEMBL12784109 0.79 MAPT (0.50) MAPTHCAR2ALDH1A1TTRDPP4
SCHEMBL17398721 0.77 MAPT (0.42) MAPTHCAR2ALDH1A1PPARDTTR
SCHEMBL13502893 0.76 MAPT (0.47) MAPTHCAR2ALDH1A1TTRDPP4
Butyric Acid SCHEMBL11237541 0.74 HCAR2 (0.42) MAPTHCAR2ALDH1A1PPARDTTR
SCHEMBL12315645 0.73 PPARD (0.47) MAPTPPARDFNTAFNTBPGGT1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080085273-A1 VEHICLE FOR THE TRANSPORT OF A CHOSEN MOLECULE TO A CELL SYNVOLUX IP B.V. (NL) 2008-04-10 US disclosed
EP-0842197-A2 BROAD SPECIFICITY ANTIBODIES THE MINISTER OF AGRICULTURE FISHERIES AND FOOD IN HER BRITANNIC MAJESTY'S GOVERNMENT OF THE UNITED KINGDOM OF GREAT BRITAIN (GB) 1998-05-20 EP disclosed
WO-1997005170-A2 BROAD SPECIFICITY ANTIBODIES THE MINISTER OF AGRICULTURE FISHERIES & FOOD IN HER BRITANNIC MAJESTY'S GOVERNMENT OF THE UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND (GB) 1997-02-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080085273-A1 VEHICLE FOR THE TRANSPORT OF A CHOSEN MOLECULE TO A CELL EPCAM, CD44, SELE MAPT 3106/4885HCAR2 1118/4885ALDH1A1 2664/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.